Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation
Clinical trial NCT07093008 · COMPLETED
Trial details
- NCT number
- NCT07093008
- Sponsor
- AQILION AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-13
- Primary completion
- 2025-07-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.